.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, 1906 concentrated 94.65% of sales in Capsules while Edible contributed 5.05%, signaling a category profile that tightened year over year with Capsules down 49.22% YoY but only 2.38% MoM, versus Edible falling 56.48% YoY and 16.56% MoM. Niche experiments emerged: Concentrates rose 150.30% YoY and 62.72% MoM but held just 0.30% share, while Pre-Roll jumped 95.44% MoM despite a 33.45% YoY decline and a 0.01% share. With average price up 2.18% YoY to $21.01 and Capsules at $20.83, the mix shows reliance on a single format with limited buffer from smaller lines, implying that stability hinges on maintaining Capsules velocity while testing scalable extensions where momentum (e.g., Concentrates’ 62.72% MoM) can translate into material share.
The mix shift implies a defensive posture: a relatively shallow 2.38% MoM dip in Capsules mitigates broader -49.55% YoY brand contraction, while steeper MoM pressure in Edible at 16.56% signals diminishing incremental reach. Rapid but low-base gains in Concentrates (150.30% YoY) and Pre-Roll (95.44% MoM) indicate option value rather than near-term lift, and the 1st-place Capsules rank in Illinois indicates that geographic and format leadership can still anchor share if replicated. The pattern suggests prioritizing Capsules-led market beachheads where rank can be sustained, paired with disciplined scaling of Concentrates as a second pillar, because small-format volatility will not offset a 49.22% YoY Capsules decline without targeted expansion.
Competitive Landscape
1906 sits at #1 in New York Capsules in May 2026, unchanged from #1 a year earlier, and has held #1 for the past three months, while peaking at #1 in May 2026; in contrast, Level holds #2 with a -17.0% year-over-year sales change, and Canna Clinicals sits at #5 after sliding from #3 year over year with a -37.5% decline, indicating that 1906’s flat YoY rank at the top is less about upward movement and more about competitors ceding ground, which implies sustained leadership driven by relative outperformance rather than incremental share capture.
Notable Products
Boost Plus Pouch Tablets 3-Pack (90mg) posted the largest movement in May 2026 with +97.4% MoM and a jump into rank 8, while CBD/THC 5:1 Chill Tablets 20-Pack (500mg CBD, 100mg THC) fell -11.3% MoM at rank 3. The flagship CBD/THC 1:1 Bliss Tablets 20-Pack (100mg CBD, 100mg THC) held rank 1 with a -5.6% MoM dip, as Boost Drops Pills 20-Pack (100mg) rose +27.2% at rank 2. Eight of the top ten are Capsules, concentrating share in a single format even as the lone Edible sits at rank 10 with no reported MoM change. The pattern implies 1906 is tilting further toward smaller-pack Capsules that are gaining momentum at mid-table ranks, even as the largest-volume SKUs soften at the top.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
